OLMETEC Side Effects

6585219-6 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Pyrexia
on Feb 05, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, pyrexia. Olmetec dosage: 40 Mg, 1x/day. During the same period patient was treated with AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), CALBLOCK (16 Mg, 1x/day) (View Calblock Review and Calblock Label ), MAINTATE (5 Mg, 1x/day) (View Maintate Review and Maintate Label ), TAKEPRON (30 Mg, 1x/day) (View Takepron Review and Takepron Label ), CRESTOR (2.5 Mg, 1x/day) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6348290-2 | Jaundice, Liver Disorder
Patient was taking Olmetec (View Usage). Patient had the following side effects: jaundice (What is jaundice?), liver disorder on Aug 24, 2009 from JAPAN Additional patient health information: Female patient , 45 years of age, was diagnosed with hypertension and. Olmetec dosage: 20 Mg, Per Oral. During the same period patient was treated with TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), PRAVATIN (PRAVASTATIN SODIUM) (View Pravatin (pravastatin Sodium) Review and Pravatin (pravastatin Sodium) Label ), EPADEL S (ETHYL ICOSAPENTATE) (View Epadel S (ethyl Icosapentate) Review and Epadel S (ethyl Icosapentate) Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ). Patient was hospitalized.

6026059-6 | Pancytopenia, Pernicious Anaemia
Adverse event was reported on Dec 19, 2008 by a Male patient taking Olmetec (View Usage) (Dosage: ) was diagnosed with hypertension, percutaneous coronary intervention, acute coronary syndrome, gastritis, cardiac failure congestive, hyperlipidaemia, diabetes mellitus and. Location: JAPAN , weighting 156.5 lb, After Olmetec was administered, patient had the following side effects: pancytopenia, pernicious anaemia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ZANTAC (View Zantac Review and Zantac Label ), ARELIX (View Arelix Review and Arelix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ARTIST (View Artist Review and Artist Label ), LIVALO (View Livalo Review and Livalo Label ), DIBETOS (View Dibetos Review and Dibetos Label ). Patient was hospitalized.

5987558-6 | Pancytopenia, Pernicious Anaemia
on Nov 27, 2008 Male patient from JAPAN , weighting 156.5 lb, was diagnosed with hypertension, cardiac failure congestive, hyperlipidaemia, percutaneous coronary intervention, acute coronary syndrome, diabetes mellitus, gastritis and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, pernicious anaemia. Olmetec dosage: . During the same period patient was treated with ARELIX (View Arelix Review and Arelix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ARTIST (View Artist Review and Artist Label ), LIVALO (View Livalo Review and Livalo Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIBETOS (View Dibetos Review and Dibetos Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.


5844360-3 | Cholelithiasis, Hepatitis Acute
on Jul 24, 2008 Female patient from JAPAN , 64 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: cholelithiasis, hepatitis acute. Olmetec dosage: 20 Mg (20 Mg, 1 In 1 D), Per Oral. Patient was hospitalized.

5404730-4 | Cerebral Infarction, Dizziness, Lacunar Infarction
Patient was taking Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: cerebral infarction, dizziness (What is dizziness?), lacunar infarction on Jul 17, 2007 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 131.2 lb, was diagnosed with essential hypertension and. Olmetec dosage: 10 Mg (10 Mg, 1 In 1 D), Per Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ).

5400634-1 | Blood Cholesterol Increased, Blood Glucose Increased, Haemoglobin Decreased, Hepatitis, Red Blood Cell Count Decreased
Adverse event was reported on Jul 11, 2007 by a Female patient taking Olmetec (View Usage) (Dosage: 20 Mg (20 Mg, 1 In 1 D), Per Oral) was diagnosed with hypertension and. Location: JAPAN , 75 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood glucose increased, haemoglobin decreased, hepatitis (What is hepatitis?), red blood cell count decreased. Patient was hospitalized.

5400501-3 | Libido Decreased
on Jul 09, 2007 Male patient from FRANCE , 38 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: libido decreased. Olmetec dosage: (1 In 1 D), Oral. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

5378242-0 | Acute Respiratory Failure, Blood Pressure Inadequately Controlled, Diabetes Mellitus Inadequate Control, Glycosylated Haemoglobin Increased
on Jun 14, 2007 Male patient from JAPAN , weighting 175.7 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: acute respiratory failure, blood pressure inadequately controlled, diabetes mellitus inadequate control, glycosylated haemoglobin increased. Olmetec dosage: 20 Mg (20 Mg, 1 In 1 D), Per Oral. During the same period patient was treated with AMLODIN (AMLODIPINE BESILATE) (TABLET) (AMLODIPINE BESILATE) (5 Mg (5 Mg, 1 In 1 D), Per Oral) (View Amlodin (amlodipine Besilate) (tablet) (amlodipine Besilate) Review and Amlodin (amlodipine Besilate) (tablet) (amlodipine Besilate) Label ), ISOCLINE (CLOTIAZEPAM) (CLOTIAZEPAM) (15 Mg, Per Oral) (View Isocline (clotiazepam) (clotiazepam) Review and Isocline (clotiazepam) (clotiazepam) Label ), DIBETOS B (BUFORMIN HYDROCHLORIDE) (TABLET) (BUFORMIN HYDROCHLORIDE) (50 Mg (50 Mg, 1 In 1 D), Per Oral) (View Dibetos B (buformin Hydrochloride) (tablet) (buformin Hydrochloride) Review and Dibetos B (buformin Hydrochloride) (tablet) (buformin Hydrochloride) Label ), AMARYL (8 Mg (4 Mg, 2 In 1 D), Per Oral) (View Amaryl Review and Amaryl Label ), ACTOS (15 Mg (15 Mg, 1 In 1 D), Per Oral) (View Actos Review and Actos Label ). Patient was hospitalized.

5291419-8 | Cystitis, Diarrhoea, Dyspepsia, Labile Blood Pressure, Renal Failure Acute, Urinary Tract Infection Enterococcal, Vomiting, Weight Increased
Patient was taking Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis, diarrhoea, dyspepsia, labile blood pressure, renal failure acute, urinary tract infection enterococcal, vomiting, weight increased on Mar 19, 2007 from FRANCE Additional patient health information: Male patient , 56 years of age, was diagnosed with hypertension and. Olmetec dosage: . During the same period patient was treated with BISOPRODOL FUMARATE (View Bisoprodol Fumarate Review and Bisoprodol Fumarate Label ), MEDIATOR (View Mediator Review and Mediator Label ), FOLFOX 4 (View Folfox-4 Review and Folfox-4 Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

5285399-9 | Blood Pressure Decreased
Adverse event was reported on Mar 15, 2007 by a Female patient taking Olmetec (View Usage) (Dosage: 5 Mg Qd Po) was diagnosed with essential hypertension and. Location: JAPAN , 70 years of age, weighting 72.75 lb, Patient had the following side effects: blood pressure decreased. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ).

5284428-6 | Disease Recurrence, Hepatic Function Abnormal, Hepatitis B
on Mar 16, 2007 Female patient from JAPAN , 58 years of age, weighting 127.4 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: disease recurrence, hepatic function abnormal, hepatitis b (What is hepatitis b?). Olmetec dosage: 20 Mg Qd Po.

5284425-0 | Intestinal Obstruction
on Mar 15, 2007 Male patient from JAPAN , 56 years of age, weighting 158.7 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ).

5283153-5 | Renal Impairment
Patient was taking Olmetec (View Usage). Patient had the following side effects: renal impairment on Mar 12, 2007 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 129.0 lb, was diagnosed with essential hypertension and. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), NORVASC (View Norvasc Review and Norvasc Label ), ADALAT (View Adalat Review and Adalat Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

5283152-3 | Condition Aggravated, Lymphocyte Stimulation Test Positive, Nephrogenic Anaemia, Uterine Leiomyoma
Adverse event was reported on Mar 12, 2007 by a Female patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with hypertension and. Location: JAPAN , 37 years of age, After Olmetec was administered, patient had the following side effects: condition aggravated, lymphocyte stimulation test positive, nephrogenic anaemia, uterine leiomyoma. During the same period patient was treated with AMLODIN (View Amlodin Review and Amlodin Label ), LASIX (View Lasix Review and Lasix Label ), CALBLOCK (View Calblock Review and Calblock Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), SURULAC S (View Surulac S Review and Surulac S Label ). Patient was hospitalized.

5283145-6 | Blood Glucose Abnormal, Dizziness, Fall, Orthostatic Hypotension
on Mar 12, 2007 Female patient from JAPAN , 72 years of age, weighting 108.0 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose abnormal, dizziness (What is dizziness?), fall (What is fall?), orthostatic hypotension. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with LUVOX (25 Mg Qd Po) (View Luvox Review and Luvox Label ), CARDENALIN (2 Mg Qd Po) (View Cardenalin Review and Cardenalin Label ), SINLESTAL (1 Df Bid Po) (View Sinlestal Review and Sinlestal Label ), DIOVAN (View Diovan Review and Diovan Label ), MAINTATE (View Maintate Review and Maintate Label ), ATELEC (View Atelec Review and Atelec Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), DIBETOS B (View Dibetos B Review and Dibetos B Label ). Patient was hospitalized.

5279387-6 | Erythema, Pemphigus, Pruritus
on Mar 07, 2007 Female patient from JAPAN , 77 years of age, was diagnosed with hypertension, hyperlipidaemia and was treated with Olmetec (View Usage). Patient had the following side effects: erythema, pemphigus (What is pemphigus?), pruritus. Olmetec dosage: . During the same period patient was treated with LIVARO (1 Mg Qd Po) (View Livaro Review and Livaro Label ), ASPIRIN (100 Mg Qd Po) (View Aspirin Review and Aspirin Label ).

5278031-1 | Blood Pressure Decreased
Patient was taking Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: blood pressure decreased on Mar 06, 2007 from JAPAN Additional patient health information: Female patient , 70 years of age, weighting 72.75 lb, was diagnosed with essential hypertension and. Olmetec dosage: 5 Mg Qd Po. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ).

5271883-0 | Intestinal Obstruction
Adverse event was reported on Mar 02, 2007 by a Male patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd;po) was diagnosed with essential hypertension and. Location: JAPAN , 56 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: intestinal obstruction. During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ).

5271868-4 | Liver Disorder, Stevens-johnson Syndrome
on Mar 05, 2007 Male patient from JAPAN , 80 years of age, weighting 138.9 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: liver disorder, stevens-johnson syndrome. Olmetec dosage: 20 Mg Daily Po. During the same period patient was treated with ZITHROMAC (250 Mg Daily Po) (View Zithromac Review and Zithromac Label ), LYSOZYME (View Lysozyme Review and Lysozyme Label ), LORFENAMIN (250 Mg Daily Po) (View Lorfenamin Review and Lorfenamin Label ), CLINDAMYCIN (600 Mg Daily Iv) (View Clindamycin Review and Clindamycin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), GASCON (View Gascon Review and Gascon Label ), EPADEL (View Epadel Review and Epadel Label ). Patient was hospitalized.

5271865-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal
on Mar 02, 2007 Male patient from JAPAN , 65 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), BONALON (View Bonalon Review and Bonalon Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5268942-5 | Diabetes Mellitus Inadequate Control, Dizziness, Fall
Patient was taking Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, dizziness (What is dizziness?), fall (What is fall?) on Feb 26, 2007 from JAPAN Additional patient health information: Female patient , 72 years of age, weighting 108.0 lb, was diagnosed with essential hypertension and. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with LUVOX (25 Mg Qd Po) (View Luvox Review and Luvox Label ), CARDENALIN (2 Mg Qd Po) (View Cardenalin Review and Cardenalin Label ), SINLESTAL (1 Df Bid Po) (View Sinlestal Review and Sinlestal Label ), DIOVAN (View Diovan Review and Diovan Label ), MAINTATE (View Maintate Review and Maintate Label ), ATELEC (View Atelec Review and Atelec Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), DIBETOS (View Dibetos Review and Dibetos Label ). Patient was hospitalized.

5257753-2 | Pemphigus
Adverse event was reported on Feb 16, 2007 by a Female patient taking Olmetec (View Usage) (Dosage: ) was diagnosed with hypertension, hyperlipidaemia and. Location: JAPAN , 77 years of age, Patient had the following side effects: pemphigus (What is pemphigus?). During the same period patient was treated with LIVARO (View Livaro Review and Livaro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5256005-4 | Hepatic Function Abnormal
on Feb 14, 2007 Female patient from JAPAN , 58 years of age, weighting 127.4 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: hepatic function abnormal. Olmetec dosage: 20 Gm Qd Po.

5252895-X | Malaise, Renal Failure
on Feb 15, 2007 Male patient from JAPAN , 72 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, renal failure. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized and became disabled.

5252891-2 | Liver Disorder, Stevens-johnson Syndrome
Patient was taking Olmetec (View Usage). Patient had the following side effects: liver disorder, stevens-johnson syndrome on Feb 15, 2007 from JAPAN Additional patient health information: Male patient , 80 years of age, weighting 138.9 lb, was diagnosed with hypertension and. Olmetec dosage: 20 Mg Daily Po. During the same period patient was treated with ZITHROMAC (250 Mg Daily Po) (View Zithromac Review and Zithromac Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), GASCON (View Gascon Review and Gascon Label ), EPADEL (View Epadel Review and Epadel Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), ADETPHOS (View Adetphos Review and Adetphos Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

5252872-9 | Eosinophil Percentage Increased
Adverse event was reported on Feb 13, 2007 by a Male patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with hypertension and. Location: JAPAN , 71 years of age, weighting 155.2 lb, After Olmetec was administered, patient had the following side effects: eosinophil percentage increased.

5235149-7 | Hypoglycaemic Unconsciousness
on Jan 24, 2007 Female patient from JAPAN , 80 years of age, weighting 94.80 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic unconsciousness. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with FOSAMAC (View Fosamac Review and Fosamac Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), METHYLCOBAL (View Methylcobal Review and Methylcobal Label ), ANPLAG (View Anplag Review and Anplag Label ), MEXITIL (View Mexitil Review and Mexitil Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FARNEZONE (View Farnezone Review and Farnezone Label ). Patient was hospitalized.

5232396-5 | Cerebral Infarction
on Jan 23, 2007 Male patient from JAPAN , 59 years of age, weighting 172.0 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: cerebral infarction. Olmetec dosage: 40 Mg Qd Po. During the same period patient was treated with ODRIC (View Odric Review and Odric Label ), CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5230774-1 | Diarrhoea, Infection, Pancytopenia, Respiratory Disorder
Patient was taking Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: diarrhoea, infection (What is infection?), pancytopenia, respiratory disorder on Jan 19, 2007 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with hypertension, prophylaxis and. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with MUCOSTA (1 Df Tid Po) (View Mucosta Review and Mucosta Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), ZANTAC (View Zantac Review and Zantac Label ), NIFESLOW (View Nifeslow Review and Nifeslow Label ), ADALAT (View Adalat Review and Adalat Label ), NORVASC (View Norvasc Review and Norvasc Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5228728-4 | Cerebral Infarction, Depressed Level Of Consciousness, Hypotension, Renal Disorder
Adverse event was reported on Jan 17, 2007 by a Male patient taking Olmetec (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 46 years of age, Patient experienced the following unwanted or unexpected effects: cerebral infarction, depressed level of consciousness, hypotension, renal disorder. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ARTIST (View Artist Review and Artist Label ). Patient was hospitalized.

5228727-2 | Angiopathy, Paraesthesia
on Jan 18, 2007 Female patient from GERMANY , 51 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: angiopathy, paraesthesia. Olmetec dosage: 10 Mg Qd Po. Patient was hospitalized.

5228655-2 | Hepatitis Acute
on Jan 18, 2007 Female patient from JAPAN , 56 years of age, weighting 119.0 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: hepatitis acute. Olmetec dosage: 10 Mg Qd Po. During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5224933-1 | Eosinophil Percentage Increased, Rash
Patient was taking Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil percentage increased, rash (What is rash?) on Jan 12, 2007 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with hypertension and. Olmetec dosage: 20 Mg Qd; Po.

5224919-7 | Eczema, Eosinophilia, Pruritus
Adverse event was reported on Jan 12, 2007 by a Female patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with essential hypertension, osteoporosis (What is osteoporosis?) and. Location: SWITZERLAND , 66 years of age, Patient had the following side effects: eczema (What is eczema?), eosinophilia, pruritus. During the same period patient was treated with BONVIVA (View Bonviva Review and Bonviva Label ), ADALAT (30 Mg Qd Po) (View Adalat Review and Adalat Label ). Patient was hospitalized.

5224042-1 | Leukopenia, Thrombocytopenia
on Jan 12, 2007 Male patient from JAPAN , 58 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: leukopenia, thrombocytopenia. Olmetec dosage: 10 Mg Qd Po.

5223208-4 | Cerebral Infarction
on Jan 11, 2007 Male patient from JAPAN , 64 years of age, weighting 146.2 lb, was diagnosed with essential hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIOVAN (View Diovan Review and Diovan Label ), GLIMICRON (View Glimicron Review and Glimicron Label ).

5215667-8 | Anxiety, Panic Attack
Patient was taking Olmetec (View Usage). Patient had the following side effects: anxiety (What is anxiety?), panic attack on Jan 02, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 76 years of age, weighting 149.9 lb, was diagnosed with hypertension and. Olmetec dosage: 10 Mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), COLOFAC (View Colofac Review and Colofac Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5207362-6 | Leukopenia, Thrombocytopenia
Adverse event was reported on Dec 27, 2006 by a Male patient taking Olmetec (View Usage) (Dosage: 10 Mg Qd Po) was diagnosed with hypertension and. Location: JAPAN , 58 years of age, weighting 154.3 lb, After Olmetec was administered, patient had the following side effects: leukopenia, thrombocytopenia.

5201629-3 | Cerebral Infarction, Depressed Level Of Consciousness, Hypotension, Renal Disorder
on Dec 14, 2006 Male patient from JAPAN , 46 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, depressed level of consciousness, hypotension, renal disorder. Olmetec dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ARTIST (View Artist Review and Artist Label ). Patient was hospitalized.

5201628-1 | Pancytopenia, Respiratory Disorder
on Dec 26, 2006 Male patient from JAPAN , 67 years of age, was diagnosed with hypertension, prophylaxis and was treated with Olmetec (View Usage). Patient had the following side effects: pancytopenia, respiratory disorder. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with MUCOSTA (1 Df Tid Po) (View Mucosta Review and Mucosta Label ), SELOKEN (View Seloken Review and Seloken Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), ZANTAC (View Zantac Review and Zantac Label ), NIFESLOW (View Nifeslow Review and Nifeslow Label ), ADALAT (View Adalat Review and Adalat Label ), NORVASC (View Norvasc Review and Norvasc Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5199850-6 | Malaise, Renal Failure
Patient was taking Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: malaise, renal failure on Dec 18, 2006 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 132.3 lb, was diagnosed with hypertension and. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized and became disabled.

5197244-0 | Interstitial Lung Disease
Adverse event was reported on Dec 13, 2006 by a Male patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with hypertension and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with MOBIC (10 Mg Qd Po) (View Mobic Review and Mobic Label ), FASTIC (90 Mg Bid Po) (View Fastic Review and Fastic Label ), LIPIDIL (20 Mg Bid Po) (View Lipidil Review and Lipidil Label ), ARTIST (View Artist Review and Artist Label ), CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5197225-7 | Hypoglycaemia, Loss Of Consciousness
on Dec 19, 2006 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient had the following side effects: hypoglycaemia, loss of consciousness. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with FOSAMAC (View Fosamac Review and Fosamac Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PANALDINE (View Panaldine Review and Panaldine Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), ANPLAG (View Anplag Review and Anplag Label ), MEXITIL (View Mexitil Review and Mexitil Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FARNEZONE (View Farnezone Review and Farnezone Label ). Patient was hospitalized.

5192227-9 | Pancytopenia, Respiratory Disorder
on Dec 07, 2006 Male patient from JAPAN , 67 years of age, was diagnosed with hypertension, prophylaxis and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: pancytopenia, respiratory disorder. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with MUCOSTA (1 Df Tid Po) (View Mucosta Review and Mucosta Label ), SELOKEN (View Seloken Review and Seloken Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), ZANTAC (View Zantac Review and Zantac Label ), NIFESLOW (View Nifeslow Review and Nifeslow Label ), ADALAT (View Adalat Review and Adalat Label ), NORVASC (View Norvasc Review and Norvasc Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5192226-7 | Hepatitis Acute
Patient was taking Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute on Dec 07, 2006 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with hypertension and. Olmetec dosage: 10 Mg Qd Po. During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5191585-9 | Cerebrovascular Accident
Adverse event was reported on Dec 07, 2006 by a Female patient taking Olmetec (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with hypertension and. Location: ECUADOR , 65 years of age, Patient had the following side effects: cerebrovascular accident. Patient was hospitalized.

5189894-2 | Hypoglycaemic Unconsciousness
on Dec 04, 2006 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Olmetec (View Usage). After Olmetec was administered, patient had the following side effects: hypoglycaemic unconsciousness. Olmetec dosage: 20 Mg Qd Po. During the same period patient was treated with FOSAMAC (View Fosamac Review and Fosamac Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PANALDINE (View Panaldine Review and Panaldine Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), ANPLAG (View Anplag Review and Anplag Label ), MEXITIL (View Mexitil Review and Mexitil Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), FARNEZONE (View Farnezone Review and Farnezone Label ). Patient was hospitalized.

5189056-9 | Acute Respiratory Distress Syndrome, Hyperlipidaemia, Interstitial Lung Disease
on Dec 07, 2006 Male patient from JAPAN , 61 years of age, weighting 149.9 lb, was diagnosed with hypertension and was treated with Olmetec (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, hyperlipidaemia, interstitial lung disease. Olmetec dosage: 20 Mg Bid Po. During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ), NICHOLASE (View Nicholase Review and Nicholase Label ), HUSCODE (View Huscode Review and Huscode Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), ZANTAC (View Zantac Review and Zantac Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5189055-7 | Leukopenia, Thrombocytopenia
Patient was taking Olmetec (View Usage). Patient had the following side effects: leukopenia, thrombocytopenia on Dec 01, 2006 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with hypertension and. Olmetec dosage: 10 Mg Qd Po.